Broadridge Financial Solutions, Inc. BR
Spruce Point argues Broadridge is a low-tech BPO masquerading as SaaS, with a failing $1B+ UBS buildout, accounting red flags, and likely SEC scrutiny — 65-75% downside to $37-52.
Thesis
Spruce Point argues Broadridge Financial Solutions is a misunderstood S&P 500 component: not the SaaS/fintech leader it promotes itself as, but a low-margin business process outsourcer where roughly 40% of revenue comes from mundane print and distribution work like American Express statements. The firm sees mounting financial stress — working capital negative in six of nine quarters, suspended free cash flow guidance, and segment margins quietly restated lower. The $1B+ UBS Wealth Management buildout has produced no booked revenue, carries a 70-83 year payback, and would, properly expensed, breach BR's 3.5x leverage covenant. The 2021 Itiviti acquisition added $2.2bn of debt at 10x sales on exaggerated synergy claims. Four ethics-policy revisions, an SEC comment letter, a former SEC commissioner appointed to the board, and recent CTO/CAO replacements all suggest active regulatory scrutiny. Sum-of-parts target $37.35-$52.30 implies 65-75% downside from $154.
SCQA
Broadridge is an S&P 500 component promoted as a defensive SaaS/fintech leader processing proxy statements and investor communications, viewed as infrastructure-grade with stable recurring revenue and SaaS-like margins.
In reality 40% of revenue is low-margin BPO printing, gross margins of 28% lag SaaS peers at 55%, the $1B+ UBS project has booked zero revenue, and four ethics-policy rewrites plus an SEC comment letter point to active investigation.
Sell BR; force management to expense capitalized UBS conversion costs (triggering covenant breach), take impairment charges, and justify the inflated $60bn TAM and the Itiviti synergy claims.
Sum-of-parts valuing ICS at 1.0-1.2x sales and GTO at 2.5-3.0x sales implies a $37.35-$52.30 share price versus $154, or 65-75% downside risk.
The three reasons
- 1
BR poses as a SaaS fintech but ~40% of revenue is low-margin BPO print/distribution work
- 2
$1B+ UBS wealth platform is a sinkhole with 70-83 year payback; expensing it breaches the debt covenant
- 3
SEC comment letter, four ethics-policy rewrites, ex-SEC commissioner on board, and CTO/CAO turnover suggest active investigation
Primary demands
- Sell Broadridge stock — Strong Sell opinion with 65%-75% downside risk
- Immediately expense the hundreds of millions of capitalized UBS conversion costs, which would put BR in violation of its debt covenant
- Cease aggressive capitalization policies and take an impairment charge on the UBS wealth platform
- Provide coherent justification for the recent $8bn TAM increase to $60bn
- Disclose the magnitude of UBS project investment and segment-level allocation of software spending
KPIs cited
Pattern membership
Precedents cited
- Spruce Point's prior S&P 500 short on Stryker (NYSE: SYK, 2022)
- Spruce Point's prior short on Church & Dwight (NYSE: CHD, 2019)
- Spruce Point's prior short on Mettler-Toledo (NYSE: MTD, 2019)
- Spruce Point's prior short on A.O. Smith (NYSE: AOS, 2019)
Composition what's on the 81 slides
Slide gallery ·
Notes
Classic Spruce Point short-report template: teal/grey palette, red-flag icons, yellow callout boxes, side-by-side 'Stock Promotion vs Cold Reality' framing. Cover slide uses a striking visual metaphor (rats and cockroaches infesting a Broadridge product UI screenshot with a 'Project Failure Imminent' overlay). The timeline slide (p.10) is a strong rhetorical device — chronologically sequencing whistleblower suit, CFO departure, ethics-policy rewrites, ex-SEC commissioner board addition, CTO/CAO turnover, and SEC comment letter to imply a fraud-exposure narrative without making explicit accusations. Track record framing on slide 3 quoting CIO Ben Axler ('Being an S&P 500 index member is a validation of absolutely nothing') functions as both authority signal and precedent citation. No explicit short-position size disclosed (typical for Spruce Point). Date inferred from filename (9-28-2022) and corroborated by report references to recent SEC filings. Author attribution to Ben Axler based on the cover page and quote attribution; firm-level authorship is the dominant frame.